15 Best Fundamental Stocks to Buy According to Hedge Funds

Page 2 of 15

14. DexCom Inc. (NASDAQ:DXCM)

5-Year Revenue Growth Rate: 22.27%

Number of Hedge Fund Holders: 60

DexCom, Inc. (NASDAQ:DXCM) ranks among the best fundamental stocks to buy according to hedge funds. Oppenheimer reaffirmed its $95 price target and Outperform rating for DexCom, Inc. (NASDAQ:DXCM) on June 24 in response to remarks made by Health and Human Services Secretary RFK Jr. regarding a significant wearables campaign.

At a June 24 hearing of the House Energy and Commerce Health Subcommittee, Secretary Kennedy declared that HHS would soon begin “one of the biggest advertising campaigns in HHS history” to promote wearables among Americans, emphasizing the advantages of glucose monitors.

The possibility of a major government marketing campaign is encouraging for companies that provide continuous glucose monitoring (CGM), as noted by Oppenheimer, who also observed that the Secretary’s remarks may indicate interest in future coverage of over-the-counter CGMs.

Oppenheimer also noted recent advancements in CGM coverage for non-insulin Type 2 diabetes, pointing to a DexCom-led randomized controlled trial that is expected to wrap up in late 2025 or early 2026 for Medicare patients with non-insulin Type 2 diabetes.

DexCom, Inc. (NASDAQ:DXCM) is a medical device company that manufactures continuous glucose monitoring (CGM) systems to allow real-time health management control.

Page 2 of 15